Evidence map›Paper›PMID 30005136›Full record

ArticleGenesis (New York, N.Y. : 2000)2018

Mutational analysis of a Drosophila neuroblast enhancer governing nubbin expression during CNS development.

Jermaine Ross, Alexander Kuzin, Thomas Brody, Ward F Odenwald

Open access · hybridAbstract read
In one paragraph

Article in Genesis (New York, N.Y. : 2000), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jermaine RossNeural Cell-Fate Determinants Section, NINDS, NIH, Bethesda, Maryland.
Alexander KuzinNeural Cell-Fate Determinants Section, NINDS, NIH, Bethesda, Maryland.ORCID 0000-0002-2793-3965
Thomas BrodyNeural Cell-Fate Determinants Section, NINDS, NIH, Bethesda, Maryland.ORCID 0000-0002-1445-8675
Ward F OdenwaldNeural Cell-Fate Determinants Section, NINDS, NIH, Bethesda, Maryland.
National Institutes of Health · US

Funding

Intramural Research Program of the NIH, NINDS
6 · The paper itself

Abstract

While developmental studies of Drosophila neural stem cell lineages have identified transcription factors (TFs) important to cell identity decisions, currently only an incomplete understanding exists of the cis-regulatory elements that control the dynamic expression of these TFs. Our previous studies have identified multiple enhancers that regulate the POU-domain TF paralogs nubbin and pdm-2 genes. Evolutionary comparative analysis of these enhancers reveals that they each contain multiple conserved sequence blocks (CSBs) that span TF DNA-binding sites for known regulators of neuroblast (NB) gene expression in addition to novel sequences. This study functionally analyzes the conserved DNA sequence elements within a NB enhancer located within the nubbin gene and highlights a high level of complexity underlying enhancer structure. Mutational analysis has revealed CSBs that are important for enhancer activation and silencing in the developing CNS. We have also observed that adjusting the number and relative positions of the TF binding sites within these CSBs alters enhancer function.

Indexed as

AnimalsBase SequenceBinding SitesCentral Nervous SystemConserved SequenceDrosophilaDrosophila ProteinsEnhancer Elements, GeneticGene Expression Regulation, DevelopmentalGenes, ReporterHomeodomain ProteinsNeural Stem CellsPhylogenyPOU Domain FactorsTranscription FactorsTranscription, GeneticDrosophila ProteinsHomeodomain Proteinsnub protein, DrosophilaPOU Domain FactorsTranscription FactorsCNSDrosophilaenhancerstranscriptional regulation

Identifiers

PMID30005136
PMCPMC6175444
OpenAlexW2884665617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.